KRT80 and cancer: Furthermore, considering the widespread dysregulation of KRT80 and the emerging evidence supporting the tumor-suppressive role of miR-195-5p in multiple cancer types [31], this therapeutic strategy holds strong potential for broader oncological applications, extending beyond colorectal cancer to other malignancies characterized by similar molecular alterations.